Pingora Partners’s Gilead Sciences GILD Stock Holding History

Pingora Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$69.7K	Hold	500	–	–	0.04%	113
2025 Q4	$61.4K	Hold	500	–	–	0.04%	114
2025 Q3	$55.5K	Hold	500	–	–	0.04%	118
2025 Q2	$55.4K	Hold	500	–	–	0.04%	117
2025 Q1	$56K	Sell	500 -200	-29%	-$20.6K	0.04%	109
2024 Q4	$64.7K	Hold	700	–	–	0.04%	112
2024 Q3	$58.7K	Hold	700	–	–	0.04%	116
2024 Q2	$48K	Hold	700	–	–	0.03%	124
2024 Q1	$51.3K	Buy	700 +200	+40%	+$15.4K	0.04%	130
2023 Q4	$40.5K	Buy	+500	New	+$38.9K	0.04%	116

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pingora Partners's GILD Position: Q1 2026 in Review

Pingora Partners held its Gilead Sciences (GILD) position steady in Q1 2026 at 500 shares worth $69.7K. The position accounts for 0.04% of the portfolio, ranked #113.

Pingora Partners first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Pingora Partners held 500 shares of Gilead Sciences worth $69.7K as of Q1 2026.
Pingora Partners left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.04% of Pingora Partners's portfolio in Q1 2026, its #113 holding.
Pingora Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.